Ameritas Investment Partners, Inc. Clearside Biomedical, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $3.05 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding CLSD
# of Institutions
46Shares Held
11.6MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$13.4 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$8.75 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$6 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$3.18 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$3.15 Million0.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $240M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...